(Q44373574)
Statements
The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria (English)
W-H Boehncke
T M Zollner
F Ochsendorf
R Kaufmann
1 reference
1 reference
1 reference
1 reference